Table 2.
Predictors for BSI due to MRSA in cancer patients
| Study | Type of analysis | Predictor | Prevalence (%) | OR (95% CI) | P |
|---|---|---|---|---|---|
| Bello-Chavolla et al. 2018 [52] | Multivariate analysis | Hospital-acquired infection | 56 (58.9) | 5.54 (3.27–9.38) | < 0.001 |
| Healthcare-associated pneumonia | 19 (20.0) | 3.02 (1.63–5.59) | < 0.001 | ||
| Diabetes mellitus | 67 (18.9) | 2.09 (1.02–4.28) | 0.049 | ||
| Kang et al. 2012 [13] | Univariate analysis | Nosocomial acquisition | 45 (76.3) | 3.11 (1.43–6.77) | 0.004 |
| Indwelling urinary catheter | 25 (42.4) | 3.90 (1.67–9.12) | 0.001 | ||
| Nasogastric tube | 12 (20.3) | 5.11 (1.36–19.14) | 0.009 | ||
| ICU admission | 17 (28.8) | 4.70 (1.61–13.73) | 0.003 | ||
| Srinivasan et al. 2010 [51] | Chi-square test | Persistently positive blood cultures | 5 (50) | 0.004 | |
| Catheter removal | 6 (60) | 0.003 |
BSI bloodstream infections, MRSA Methicillin-resistant Staphylococcus aureus, OR odds ratio, CI confidence interval, ICU intensive care unit